The suppression of CD4 cells infiltration to the spinal cord in response to agonist-mediated CB2R activation in TMEV-IDD mice and inhibition of these cells from the peripheral site to CNS is the first indication of the role of CB2R in MS. This evidence concerns the gene CD4 and myeloid sarcoma.